Three Simple Portfolios
We asked the experts to recommend low-cost funds for the long term.
As we survey the wreckage of our portfolios in the new year, it's worth considering this: You can beat the great majority of investment professionals by employing simple strategies that use low-cost index funds. Index funds track a broad swath of the stock market, such as big-company stocks, small-company stocks, emerging-markets stocks, and so on.
Some of the biggest brains in the world of finance -- from Nobel Prize-winning professors, such as William F. Sharpe, to, arguably, the greatest money manager of our time, Warren Buffett -- advocate a "passive" style of investing epitomized by index funds.
The evidence seems to back up these intellectual heavyweights. Over the past 15 years through December 31, Standard & Poor's 500-stock index performed better than 71% of mutual fund managers who specialize in the stocks of large U.S. companies.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
How well have you done by picking managers who actively buy and sell securities? It's true that some fund managers can beat their relevant index. But as Princeton professor Burton Malkiel asserts in his famous book, A Random Walk Down Wall Street, there's no good way to "find such skill before it has been demonstrated over time."
Building a simple portfolio based on index funds is, well, simple. You can find my take on index funds in Three Winning Portfolios. But we thought it would be interesting to ask some of the champions of easy, low-cost investing to suggest their own portfolios.
So we kick off the Simple Portfolios corner of Kiplinger.com with recommendations from three experts. Our request was straightforward: balanced, low-cost portfolios, with no more than eight investments, for people investing for the long term. We're not fanatical about our guidelines; we allowed our experts to use actively managed funds as well as index funds. They submitted their portfolios in December 2008, and we decided to begin tracking performance as of January 1, 2009. We will rebalance the portfolios twice a year, on the last day of June and the last day of December.
The first is from Larry Swedroe, director of research for St. Louis-based Buckingham Asset Management, and author of several useful books, including The Successful Investor Today and The Only Guide to a Winning Investment Strategy You'll Ever Need.
Swedroe doesn't mince words. Believing in active management is "absurd," he says, calling it "the triumph of hope over wisdom and experience." The wise investor knows that some managers will beat the indexes occasionally, but when they do, Swedroe says, it's "purely out of luck."
Swedroe's simple portfolio reflects these sentiments, as well as the tendency of value stocks and small-company stocks to do better than other stocks over time.
Swedroe's portfolio:
15% Vanguard Value Index (symbol VIVAX) (Tracks an index of undervalued stocks from the largest 750 U.S. companies)
15% Vanguard Small Cap Value Index (VISVX) (Tracks an index of stocks of small, undervalued U.S. companies)
13% iShares MSCI EAFE Value Index (EFV) (Tracks an index of stocks of large, undervalued foreign companies)
13% iShares MSCI EAFE Small Cap Index (SCZ) (Tracks an index of stocks of small overseas companies)
4% Vanguard Emerging Markets Stock Index (VEIEX) (Tracks an index of companies from developing nations)
40% Vanguard Inflation-Protected Securities (VIPSX) (Invests at least 80% of assets in inflation-indexed bonds issued by the U.S. government)
Next is the portfolio of Princeton professor Burton Malkiel, whose latest book (with three co-authors) is From Wall Street to the Great Wall: How Investors Can Profit from China's Booming Economy.
In Malkiel's view, managers in developed markets will be hard-pressed to beat their indexes over time. So he has the bulk of his portfolio's assets in index funds. And Malkiel keeps the majority of the assets in foreign stocks because, he says, foreign markets offer better growth opportunities than the U.S. does.
While most of his portfolio consists of passively managed and exchange-traded funds, which also follow indexes, Malkiel has stakes in actively managed funds as well. (In fact, this portfolio represents his actual investments.)
He owns Vanguard Capital Opportunities because of his "enormous" respect for the managers at Primecap Management Company, who run the fund for Vanguard. Malkiel, a former director of the Vanguard Group, says he feels he can make a small bet on Primecap's expertise because the core of his portfolio is in index funds.
More interesting are his picks of Templeton Dragon and Matthew's India, both actively managed. "I believe that of all the places in the world, China and India are the two that will have the highest growth rates," says Malkiel. Templeton Dragon, a closed-end fund that focuses on Chinese stocks, is managed by longtime emerging-markets hand Mark Mobius. While Malkiel is not sure that Mobius can beat the relevant index, he thinks Mobius is an excellent manager. "If I can buy Mark Mobius at 85 cents on the dollar, I'm happy to do it." At its January 16 closing price of $16.52, Templeton Dragon sold for 6.9% less than the value of its underlying assets.
Malkiel says that there aren't many good ways to play India, and if there were a good closed-end India fund trading at a discount to its net asset value, he'd buy it. For now, he'll take the Matthew's fund.
Malkiel's portfolio:
20% Vanguard Total Stock Market ETF (VTI) (Tracks a broad index of U.S. companies)
20% Vanguard FTSE All-World ex-US ETF (VEU) (Tracks a broad index of stocks from developed and emerging foreign markets.)
20% Vanguard Total Bond Market ETF (BND) (Tracks a broad index of high-quality U.S. bonds)
10% Vanguard Capital Opportunity (VHCOX) (An actively managed fund that likes big growth companies down on their luck)
10% Vanguard Emerging Markets ETF (VWO) (Tracks an index of stocks developing nations)
10% Templeton Dragon (TDF) (Invests in stocks from China and nearby nations)
10% Matthew's India (MINDX)(Invests in stocks from India)
Given the interest in fixed-income investing (and the fear and loathing surrounding the stock market these days), we also sought a stockless portfolio. William Larkin, fixed-income portfolio manager at Cabot Money Management, in Salem, Mass., says his portfolio was originally designed for conservative clients who wanted conservative investments.
These days, though, he finds that many clients who hadn't considered themselves conservative in the past are now interested in fixed-income investing only. This portfolio represents all parts of the fixed-income market at the lowest possible cost, he says, and recently yielded 6.3%. It also has a healthy slug of inflation protection, which is particularly reassuring given all the money that's being printed for various government stimulus and rescue plans around the world.
Larkin's portfolio:
25% iShares Barclays Aggregate Bond ETF (AGG)(Tracks a broad index of high-quality U.S. bonds)
25% iShares iboxx $ Investment Grade Corporate (LQD)(Tracks an index of the most liquid, long-term corporate bonds)
10% Fidelity Floating Rate High Income (FFRHX)(Invests in floating rate bank loans that automatically adjusts to rising short-term interest rates. It offers additional inflation hedge)
10% iShares MBS Fixed Income (MBB)(Tracks a broad index mortgage-backed securities)
7.5% SPDR DB International Govt Inflation-Protected Bond (WIP)(Invests in an index of non-U.S., inflation-linked bonds)
7.5% PowerShares Emerging Markets Sovereign Debt (PCY)(Tracks an index of emerging markets government debt)
7.5% iShares Barclays TIPS Bond (TIP)(Tracks an index of inflation-protected, U.S. Treasury securities)
7.5% iShares Iboxx $ High Yield Corporate Bond (HYG)(Tracks an index of high yield bonds)
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
-
Trump Picks Dr. Oz as Head of Medicare and Medicaid
President-elect Donald Trump picked Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services. Here's what to know about the former TV host.
By Kathryn Pomroy Published
-
What's Next for MicroStrategy Stock as Bitcoin Nears $100K?
MicroStrategy stock is up more than fivefold in 2024 thanks to a furious rally in bitcoin. Here's what you need to know.
By Joey Solitro Published
-
'A Random Walk Down Wall Street' at 50
Interview 'A Random Walk Down Wall Street': 50 years on Burton Malkiel, author of the investing classic, remains a champion of index investing.
By Kim Clark Published
-
The 5 Best Actively Managed Fidelity Funds to Buy Now
mutual funds In a stock picker's market, it's sometimes best to leave the driving to the pros. These Fidelity funds provide investors solid active management at low costs.
By Kent Thune Last updated
-
The 12 Best Bear Market ETFs to Buy Now
ETFs Investors who are fearful about the more uncertainty in the new year can find plenty of protection among these bear market ETFs.
By Kyle Woodley Published
-
How Direct Indexing Could Work for You
Tax efficiency is the primary goal for many new direct indexing offerings, but they come with a lot of caveats.
By Kim Clark Published
-
Don't Give Up on the Eurozone
mutual funds As Europe’s economy (and stock markets) wobble, Janus Henderson European Focus Fund (HFETX) keeps its footing with a focus on large Europe-based multinationals.
By Rivan V. Stinson Published
-
Best Bond Funds to Buy
Investing for Income The best bond funds provide investors with income and stability – and are worthy additions to any well-balanced portfolio.
By Jeff Reeves Last updated
-
Vanguard Global ESG Select Stock Profits from ESG Leaders
mutual funds Vanguard Global ESG Select Stock (VEIGX) favors firms with high standards for their businesses.
By Rivan V. Stinson Published
-
Kip ETF 20: What's In, What's Out and Why
Kip ETF 20 The broad market has taken a major hit so far in 2022, sparking some tactical changes to Kiplinger's lineup of the best low-cost ETFs.
By Nellie S. Huang Published